We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
+1.79%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
AUM
$2.24B
AUM Growth
+$73.3M
Cap. Flow
+$40.7M
Cap. Flow %
1.82%
Top 10 Hldgs %
38.33%
Holding
400
New
26
Increased
168
Reduced
161
Closed
17
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIG icon
201
Vanguard Dividend Appreciation ETF
VIG
$112B
$878K 0.04%
3,993
+568
+17% +$124K
WMT icon
202
Walmart Inc
WMT
$889B
$833K 0.04%
7,479
-67
-0.9% -$7.19K
MCD icon
203
McDonald's
MCD
$192B
$824K 0.04%
2,695
+801
+42% +$245K
SPYD icon
204
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.68B
$820K 0.04%
18,960
+1,529
+9% +$66.2K
PULS icon
205
PGIM Ultra Short Bond ETF
PULS
$17.7B
$809K 0.04%
16,321
-417
-2% -$20.7K
PBTP icon
206
Invesco 0-5 Yr US TIPS ETF
PBTP
$106M
$789K 0.04%
30,446
+246
+0.8% +$6.43K
DE icon
207
Deere & Co
DE
$169B
$780K 0.03%
1,675
-16
-0.9% -$7.51K
SPYM
208
State Street SPDR Portfolio S&P 500 ETF
SPYM
$159B
$778K 0.03%
9,695
-402
-4% -$32K
TMO icon
209
Thermo Fisher Scientific
TMO
$208B
$770K 0.03%
1,329
-19
-1% -$10.7K
TBIL
210
F/m US Treasury 3 Month Bill Fund
TBIL
$7.21B
$764K 0.03%
15,309
+2,591
+20% +$129K
BAC icon
211
Bank of America
BAC
$436B
$733K 0.03%
13,334
+574
+4% +$30.3K
TOTL icon
212
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.1B
$729K 0.03%
18,111
+35
+0.2% +$1.42K
CVX icon
213
Chevron
CVX
$378B
$721K 0.03%
4,733
-18,498
-80% -$2.82M
IIGD icon
214
Invesco Investment Grade Defensive ETF
IIGD
$26.7M
$719K 0.03%
28,924
DBMF icon
215
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.03B
$708K 0.03%
25,246
+1,586
+7% +$45.2K
LQDH icon
216
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$503M
$705K 0.03%
7,551
-668
-8% -$62.3K
VCIT icon
217
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$696K 0.03%
8,310
+400
+5% +$33.6K
AOA icon
218
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.16B
$686K 0.03%
7,660
-419
-5% -$37.3K
ORCL icon
219
Oracle
ORCL
$345B
$685K 0.03%
3,515
-59
-2% -$14K
CGDV icon
220
Capital Group Dividend Value ETF
CGDV
$37.2B
$684K 0.03%
15,685
-5,115
-25% -$220K
AOR icon
221
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.64B
$683K 0.03%
10,501
+1,000
+11% +$64.9K
AMLP icon
222
Alerian MLP ETF
AMLP
$12.7B
$679K 0.03%
14,440
-1,025
-7% -$48K
QYLD icon
223
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.03B
$658K 0.03%
37,232
-1,097
-3% -$19.1K
RYLD icon
224
Global X Russell 2000 Covered Call ETF
RYLD
$1.37B
$652K 0.03%
42,620
-501
-1% -$7.67K
GWX icon
225
State Street SPDR S&P International Small Cap ETF
GWX
$863M
$617K 0.03%
15,092
-888
-6% -$35.7K

Similar funds

Trilogy Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Trilogy Capital held 400 positions worth $2.24B, up 3.4% from $2.16B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Trilogy Capital's Q4 2025 filing shows 26 new, 168 increased, 161 reduced and 17 closed positions. Its largest new stake was ALPS Smith Core Plus Bond ETF: 1,621,551 shares worth $42.3M. The largest sale was iShares US Treasury Bond ETF, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 4.2% of assets, up from 3.8% a quarter earlier, followed by Financials and Healthcare.

  • Trilogy Capital's largest Q4 2025 buy was ALPS Smith Core Plus Bond ETF: 1,621,551 shares worth $42.3M.
  • Trilogy Capital added most to State Street Industrial Select Sector SPDR ETF in Q4 2025, an estimated $23.3M increase.
  • Trilogy Capital's biggest Q4 2025 reduction was iShares US Treasury Bond ETF, cutting an estimated $35.7M.
  • Trilogy Capital fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $4.56M.
  • Trilogy Capital's ten largest holdings make up 38% of its $2.24B portfolio in Q4 2025.
  • Trilogy Capital opened 26 new positions and closed 17 in Q4 2025.
  • Trilogy Capital's portfolio value rose 3.4% quarter-over-quarter to $2.24B.

Based on Trilogy Capital's 13F filing for Q4 2025, filed 22 Jan 2026.